医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Fabrinet Announces Audit Committee Investigation into Accounting Matters; Postpones Fourth Quarter and Fiscal Year 2014 Earnings Release and Conference Call

2014年08月18日 PM09:30
このエントリーをはてなブックマークに追加


 

BANGKOK

Fabrinet (NYSE:FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, today announced that during the fourth quarter of the fiscal year ended June 27, 2014, certain accounting issues were discovered by management, which prompted the Audit Committee to commence an internal investigation. The Audit Committee is investigating whether there were any violations of the Company’s accounting policies associated with these potential accounting matters. The Company has also notified the SEC of the Audit Committee’s investigation.

The Audit Committee has not reached any conclusion because the investigation is ongoing, and the Company cannot predict the outcome of the investigation or when it will be completed. The Company is also currently evaluating whether there may be any deficiencies with the Company’s disclosure controls and procedures and internal control over financial reporting.

As a result, the Company is postponing its fourth quarter and fiscal year 2014 earnings release and conference call, which had been scheduled for August 18, 2014. Fabrinet will announce such results as soon as practicable following the completion of the Audit Committee’s investigation.

About Fabrinet

Fabrinet is a leading provider of advanced optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and subsystems, industrial lasers and sensors. Fabrinet offers a broad range of advanced optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, advanced packaging, integration, final assembly and test. Fabrinet focuses on production of high complexity products in any mix and any volume. Fabrinet maintains engineering and manufacturing resources and facilities in Thailand, the People’s Republic of China and the United States. For more information visit: www.fabrinet.com.

CONTACT

Investors:
Jennifer Predmore, 215-428-1797
ir@fabrinet.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in HER2-Mutated Cancer
  • 武田和Seattle Genetics呈报3期ECHELON-1临床试验的阳性数据,该试验评估ADCETRIS® (brentuximab vedotin)用于晚期霍奇金淋巴瘤的一线治疗
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-301の第I相中間データを発表
  • Intercell USA Changes Name to Valneva USA, Inc. and Expands Commercial Presence
  • ADC Therapeutics präsentiert Zwischenergebnisse aus Phase-I-Studie zu neuartigem Antikörper-Wirkstoff-Konjugat ADCT-402